Oncternal Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 12, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2019 - 2020
Market Capitalization	9	3	4	4	15	6	Upgrade
Market Cap Growth	40.37%	-11.53%	6.07%	-74.96%	161.02%	-42.43%	Upgrade
Enterprise Value	12	6	3	2	3	6	Upgrade
Last Close Price	0.04	0.02	0.03	0.10	0.39	0.42	Upgrade
PS Ratio	-	25.19	4.61	-	-	-	Upgrade
PB Ratio	2.68	-1.10	-24.22	8.20	1.29	0.46	Upgrade
P/TBV Ratio	-	-	-	8.79	1.30	5.66	Upgrade
EV/Sales Ratio	-	41.14	4.04	-	-	-	Upgrade
Debt / Equity Ratio	0.73	-0.56	-2.08	-	-	0.03	Upgrade
Asset Turnover	-	0.11	0.42	-	-	-	Upgrade
Quick Ratio	2.86	0.11	0.10	0.73	11.63	1.06	Upgrade
Current Ratio	2.87	0.11	0.13	0.80	12.02	1.51	Upgrade
Return on Equity (ROE)	-480.97%	-	-3296.90%	-208.76%	-195.32%	-40.32%	Upgrade
Return on Assets (ROA)	-37.20%	-104.16%	-103.76%	-37.23%	-31.79%	-22.99%	Upgrade
Return on Capital (ROIC)	-53.29%	-	-679.26%	-43.91%	-33.67%	-24.38%	Upgrade
Earnings Yield	-58.59%	-128.84%	-121.37%	-335.11%	-66.15%	-61.42%	Upgrade
Buyback Yield / Dilution	10.98%	-17.04%	-175.61%	-15.91%	-160.26%	-57.51%	Upgrade

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.